NSAIDs in Coronary Artery Disease Patients
Completed
- Conditions
- CAD
- Registration Number
- NCT01402804
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Brief Summary
Introduction:
Different groups already showed in retrospective subgroup analyses, that there is an increased risk for cardiovascular events in patients on a simultaneous ASA/NSAID treatment.
Methods:
Light-Transmission aggregometry
Hypothesis:
Simultaneous administration of different NSAIDs and ASA impair the platelet inhibiting effect of ASA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
- Patients on a simultaneous ASA, NSAID treatment
- > 18 years
Exclusion Criteria
- unconsciousness, not able to consent
- reanimation, cardiac shock
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thromboxane-levels and light-transmission aggregometry in response to arachidonic acid During hospital stay
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Heinrich-Heine-University
🇩🇪Düsseldorf, NRW, Germany